Your browser doesn't support javascript.
loading
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.
Comi, Giancarlo; Alroughani, Raed; Boster, Aaron L; Bass, Ann D; Berkovich, Regina; Fernández, Óscar; Kim, Ho Jin; Limmroth, Volker; Lycke, Jan; Macdonell, Richard Al; Sharrack, Basil; Singer, Barry A; Vermersch, Patrick; Wiendl, Heinz; Ziemssen, Tjalf; Jacobs, Alan; Daizadeh, Nadia; Rodriguez, Claudio E; Traboulsee, Anthony.
  • Comi G; Department of Neurology, University Vita-Salute San Raffaele, Milan, Italy.
  • Alroughani R; Department of Medicine, Amiri Hospital, Sharq, Kuwait.
  • Boster AL; OhioHealth Neurological Physicians, Columbus, OH, USA.
  • Bass AD; Neurology Center of San Antonio, San Antonio, TX, USA.
  • Berkovich R; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA/Regina Berkovich, MD, PhD, Inc., West Hollywood, CA, USA.
  • Fernández Ó; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
  • Kim HJ; Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
  • Limmroth V; Klinik für Neurologie und Palliativmedizin, Cologne, Germany.
  • Lycke J; Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
  • Macdonell RA; Department of Neurology, Austin Health and Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
  • Sharrack B; NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals, University of Sheffield, Sheffield, UK.
  • Singer BA; MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, USA.
  • Vermersch P; Univ. Lille, INSERM U995, CHU Lille, FHU Imminent, F-59000 Lille, France.
  • Wiendl H; Department of Neurology, University of Münster, Münster, Germany.
  • Ziemssen T; Center of Clinical Neuroscience, Carl Gustav Carus University Hospital, Dresden, Germany.
  • Jacobs A; Sanofi, Cambridge, MA, USA.
  • Daizadeh N; Sanofi, Cambridge, MA, USA.
  • Rodriguez CE; Sanofi, Cambridge, MA, USA.
  • Traboulsee A; Division of Neurology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Mult Scler ; 26(14): 1866-1876, 2020 12.
Article en En | MEDLINE | ID: mdl-31762387
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article